These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


268 related items for PubMed ID: 24315833

  • 1. Novel behavioural characteristics of female APPSwe/PS1ΔE9 double transgenic mice.
    Cheng D, Low JK, Logge W, Garner B, Karl T.
    Behav Brain Res; 2014 Mar 01; 260():111-8. PubMed ID: 24315833
    [Abstract] [Full Text] [Related]

  • 2. Novel behavioural characteristics of the APP(Swe)/PS1ΔE9 transgenic mouse model of Alzheimer's disease.
    Cheng D, Logge W, Low JK, Garner B, Karl T.
    Behav Brain Res; 2013 May 15; 245():120-7. PubMed ID: 23419740
    [Abstract] [Full Text] [Related]

  • 3. Visuo-spatial learning and memory deficits on the Barnes maze in the 16-month-old APPswe/PS1dE9 mouse model of Alzheimer's disease.
    O'Leary TP, Brown RE.
    Behav Brain Res; 2009 Jul 19; 201(1):120-7. PubMed ID: 19428625
    [Abstract] [Full Text] [Related]

  • 4. Cognitive phenotyping of amyloid precursor protein transgenic J20 mice.
    Karl T, Bhatia S, Cheng D, Kim WS, Garner B.
    Behav Brain Res; 2012 Mar 17; 228(2):392-7. PubMed ID: 22197298
    [Abstract] [Full Text] [Related]

  • 5. Long-term cannabidiol treatment prevents the development of social recognition memory deficits in Alzheimer's disease transgenic mice.
    Cheng D, Spiro AS, Jenner AM, Garner B, Karl T.
    J Alzheimers Dis; 2014 Mar 17; 42(4):1383-96. PubMed ID: 25024347
    [Abstract] [Full Text] [Related]

  • 6. Impaired spatial learning in the APPSwe + PSEN1DeltaE9 bigenic mouse model of Alzheimer's disease.
    Reiserer RS, Harrison FE, Syverud DC, McDonald MP.
    Genes Brain Behav; 2007 Feb 17; 6(1):54-65. PubMed ID: 17233641
    [Abstract] [Full Text] [Related]

  • 7. Sensorimotor gating and memory deficits in an APP/PS1 double transgenic mouse model of Alzheimer's disease.
    Wang H, He J, Zhang R, Zhu S, Wang J, Kong L, Tan Q, Li XM.
    Behav Brain Res; 2012 Jul 15; 233(1):237-43. PubMed ID: 22595040
    [Abstract] [Full Text] [Related]

  • 8. Effects of accelerated senescence on learning and memory, locomotion and anxiety-like behavior in APP/PS1 mouse model of Alzheimer's disease.
    Lok K, Zhao H, Zhang C, He N, Shen H, Wang Z, Zhao W, Yin M.
    J Neurol Sci; 2013 Dec 15; 335(1-2):145-54. PubMed ID: 24095271
    [Abstract] [Full Text] [Related]

  • 9. Episodic-like memory deficits in the APPswe/PS1dE9 mouse model of Alzheimer's disease: relationships to beta-amyloid deposition and neurotransmitter abnormalities.
    Savonenko A, Xu GM, Melnikova T, Morton JL, Gonzales V, Wong MP, Price DL, Tang F, Markowska AL, Borchelt DR.
    Neurobiol Dis; 2005 Apr 15; 18(3):602-17. PubMed ID: 15755686
    [Abstract] [Full Text] [Related]

  • 10. Age-related changes in visual acuity, learning and memory in the APPswe/PS1dE9 mouse model of Alzheimer's disease.
    Stover KR, Brown RE.
    Behav Brain Res; 2012 May 16; 231(1):75-85. PubMed ID: 22409975
    [Abstract] [Full Text] [Related]

  • 11. Episodic-like memory for what-where-which occasion is selectively impaired in the 3xTgAD mouse model of Alzheimer's disease.
    Davis KE, Easton A, Eacott MJ, Gigg J.
    J Alzheimers Dis; 2013 May 16; 33(3):681-98. PubMed ID: 23034524
    [Abstract] [Full Text] [Related]

  • 12. Soluble Aβ levels correlate with cognitive deficits in the 12-month-old APPswe/PS1dE9 mouse model of Alzheimer's disease.
    Zhang W, Hao J, Liu R, Zhang Z, Lei G, Su C, Miao J, Li Z.
    Behav Brain Res; 2011 Sep 23; 222(2):342-50. PubMed ID: 21513747
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Effects of progesterone administration and APPswe+PSEN1Deltae9 mutation for cognitive performance of mid-aged mice.
    Frye CA, Walf AA.
    Neurobiol Learn Mem; 2008 Jan 23; 89(1):17-26. PubMed ID: 17988898
    [Abstract] [Full Text] [Related]

  • 15. Chronic cannabidiol treatment improves social and object recognition in double transgenic APPswe/PS1∆E9 mice.
    Cheng D, Low JK, Logge W, Garner B, Karl T.
    Psychopharmacology (Berl); 2014 Aug 23; 231(15):3009-17. PubMed ID: 24577515
    [Abstract] [Full Text] [Related]

  • 16. Locomotor activity, emotionality, sensori-motor gating, learning and memory in the APPswe/PS1dE9 mouse model of Alzheimer's disease.
    O'Leary TP, Hussin AT, Gunn RK, Brown RE.
    Brain Res Bull; 2018 Jun 23; 140():347-354. PubMed ID: 29870778
    [Abstract] [Full Text] [Related]

  • 17. Early detection of memory deficits and memory improvement with vaccinia virus complement control protein in an Alzheimer's disease model.
    Pillay NS, Kellaway LA, Kotwal GJ.
    Behav Brain Res; 2008 Oct 10; 192(2):173-7. PubMed ID: 18490064
    [Abstract] [Full Text] [Related]

  • 18. Anomalies in social behaviors and exploratory activities in an APPswe/PS1 mouse model of Alzheimer's disease.
    Filali M, Lalonde R, Rivest S.
    Physiol Behav; 2011 Oct 24; 104(5):880-5. PubMed ID: 21640739
    [Abstract] [Full Text] [Related]

  • 19. Reductions in endocannabinoid levels and enhanced coupling of cannabinoid receptors in the striatum are accompanied by cognitive impairments in the AβPPswe/PS1ΔE9 mouse model of Alzheimer's disease.
    Maroof N, Ravipati S, Pardon MC, Barrett DA, Kendall DA.
    J Alzheimers Dis; 2014 Oct 24; 42(1):227-45. PubMed ID: 24844690
    [Abstract] [Full Text] [Related]

  • 20. LMN diet, rich in polyphenols and polyunsaturated fatty acids, improves mouse cognitive decline associated with aging and Alzheimer's disease.
    Fernández-Fernández L, Comes G, Bolea I, Valente T, Ruiz J, Murtra P, Ramirez B, Anglés N, Reguant J, Morelló JR, Boada M, Hidalgo J, Escorihuela RM, Unzeta M.
    Behav Brain Res; 2012 Mar 17; 228(2):261-71. PubMed ID: 22119712
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 14.